Servier – Phlebolymphology

J. ULLOA, S. CIFUENTES, A. SOLANO, and V. FIGUEROA (Colombia) review several cardiovascular disease (CVD) management guidelines published by prestigious academic associations around the globe and summarize their recommendations about the use of micronized purified flavonoid fraction (MPFF) and the corresponding level of evidence, providing clinicians with a straightforward and practical source document to include MPFF in daily practice.

C. FRANCESCHI (France) introduces the basis of the CHIVA technique (Conservative and Hemodynamic Treatment of Venous Insufficiency), including the pathophysiological perspective, and makes a comparison with the ablation technique.

R. AKHMETZIANOV (Russia) presents a review of patient-oriented diagnostic tools currently used in patients with pelvic varicose veins and provides rationale for using disease-specific tools, as highlighted in the international consensus documents on the diagnosis and treatment of pelvic congestion syndrome.

Although compression is widely prescribed for patients post endovascular thermal ablation (EVTA), there is widespread disagreement on the optimal compression regimen and whether compression is even required postoperatively. M. TAN and A. DAVIES (UK) reexamine the literature surrounding this important clinical question, presenting current clinical opinion and practices and guideline recommendations, and discuss the evidence for and against the use of compression postoperatively.

N. MORRISON (USA) provides an overview of the evidence with cyanoacrylate closure in the treatment of varicose veins.

N. KHOREV and D. KUZNETSOVA (Russia) present the results of a study that aimed to evaluate the efficacy of MPFF in patients with primary chronic venous disease using venous photoplethysmography, which is an appropriate method for the quantitative instrumental assessment of total venous reflux.

Enjoy reading this issue!
Editorial Manager
Dr H. Pelin Yaltirik